JP2023534524A5 - - Google Patents

Info

Publication number
JP2023534524A5
JP2023534524A5 JP2023503444A JP2023503444A JP2023534524A5 JP 2023534524 A5 JP2023534524 A5 JP 2023534524A5 JP 2023503444 A JP2023503444 A JP 2023503444A JP 2023503444 A JP2023503444 A JP 2023503444A JP 2023534524 A5 JP2023534524 A5 JP 2023534524A5
Authority
JP
Japan
Prior art keywords
stem cells
mesenchymal stem
ntfs
mscs
exo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023503444A
Other languages
English (en)
Japanese (ja)
Other versions
JP7691488B2 (ja
JP2023534524A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IL2021/050885 external-priority patent/WO2022018729A1/en
Publication of JP2023534524A publication Critical patent/JP2023534524A/ja
Publication of JP2023534524A5 publication Critical patent/JP2023534524A5/ja
Priority to JP2025089972A priority Critical patent/JP2025128209A/ja
Application granted granted Critical
Publication of JP7691488B2 publication Critical patent/JP7691488B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023503444A 2020-07-20 2021-07-20 肺疾患を治療するための方法及び組成物 Active JP7691488B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025089972A JP2025128209A (ja) 2020-07-20 2025-05-29 肺疾患を治療するための方法及び組成物

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063053780P 2020-07-20 2020-07-20
US63/053,780 2020-07-20
US202163133350P 2021-01-03 2021-01-03
US63/133,350 2021-01-03
PCT/IL2021/050885 WO2022018729A1 (en) 2020-07-20 2021-07-20 Methods and compositions for treating lung conditions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025089972A Division JP2025128209A (ja) 2020-07-20 2025-05-29 肺疾患を治療するための方法及び組成物

Publications (3)

Publication Number Publication Date
JP2023534524A JP2023534524A (ja) 2023-08-09
JP2023534524A5 true JP2023534524A5 (https=) 2025-01-24
JP7691488B2 JP7691488B2 (ja) 2025-06-11

Family

ID=77265158

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2023503444A Active JP7691488B2 (ja) 2020-07-20 2021-07-20 肺疾患を治療するための方法及び組成物
JP2025089972A Pending JP2025128209A (ja) 2020-07-20 2025-05-29 肺疾患を治療するための方法及び組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025089972A Pending JP2025128209A (ja) 2020-07-20 2025-05-29 肺疾患を治療するための方法及び組成物

Country Status (7)

Country Link
US (1) US20230310507A1 (https=)
EP (1) EP4181935A1 (https=)
JP (2) JP7691488B2 (https=)
AU (1) AU2021313472B2 (https=)
CA (1) CA3189818A1 (https=)
IL (1) IL299997A (https=)
WO (1) WO2022018729A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3801028A4 (en) 2018-05-30 2022-04-13 Direct Biologics LLC A growth factor and extracellular vesicle frozen or powdered additive comprising a mesenchymal stem cell (msc) preparation and methods of use
US12569517B2 (en) 2019-02-07 2026-03-10 Direct Biologics, Llc Method for treating osteoarthritis with mesenchymal stem cell exosomes
US12213995B2 (en) 2019-07-18 2025-02-04 Direct Biologics, Llc Preparations comprising mesenchymal stem cells and cannabinoids and methods of their use
CN113384597A (zh) * 2020-03-13 2021-09-14 西比曼生物科技(上海)有限公司 含人体细胞衍生的细胞膜外囊泡的雾化吸入制剂、制法及其应用
KR20230004709A (ko) 2020-04-22 2023-01-06 다이렉트 바이오로직스 엘엘씨 감염성 질환과 연관된 염증성 병태를 치료하기 위한 방법 및 조성물
WO2022114730A2 (ko) * 2020-11-26 2022-06-02 사회복지법인 삼성생명공익재단 트롬빈 처리 줄기세포에서 유래된 엑소좀을 포함하는 감염성 질환 치료용 조성물
KR20240003167A (ko) * 2022-06-30 2024-01-08 주식회사 지씨셀 편도유래줄기세포를 유효성분으로 포함하는 감염성 폐 질환의 예방 또는 치료용 조성물
WO2024236603A1 (en) * 2023-05-18 2024-11-21 Khorakiwala Zahabiya Growth factor concentrate composition
CN116897887A (zh) * 2023-07-31 2023-10-20 湖南中医药大学 一种病毒性哮喘动物模型的构建方法
US12502407B2 (en) 2024-04-25 2025-12-23 Direct Biologics, Llc Treatment of fistula with bone marrow mesenchymal stem cell derived extracellular vesicles

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080095749A1 (en) 2004-03-22 2008-04-24 Sudeepta Aggarwal Mesenchymal stem cells and uses therefor
US9901600B2 (en) 2011-03-11 2018-02-27 Children's Medical Center Corporation Methods and compositions relating to mesenchymal stem cell exosomes
DK2880151T3 (da) * 2012-08-06 2020-08-17 Brainstorm Cell Therapeutics Ltd Fremgangsmåder til frembringelse af mesenkymale stemceller, som udskiller neurotrofiske faktorer
WO2015016761A2 (en) * 2013-08-01 2015-02-05 Isletone Ab Mscs in the treatment of inflammatory pulmonary diseases
KR101843634B1 (ko) 2016-04-15 2018-03-30 사회복지법인 삼성생명공익재단 트롬빈 처리 줄기세포에서 유래된 엑소좀을 포함하는 만성폐질환 치료용 조성물
CN111212653A (zh) * 2017-08-15 2020-05-29 儿童医学中心公司 经纯化间充质干细胞外排体及其用途
GB2568255A (en) * 2017-11-08 2019-05-15 Evox Therapeutics Ltd Exosomes comprising RNA therapeutics
US12233092B2 (en) 2018-04-10 2025-02-25 Brainstorm Cell Therapeutics Ltd. MSC-NTF specific exosomes and use thereof
EP4344739A3 (en) * 2018-06-29 2024-05-29 North Carolina State University Therapeutic lung repair by inhalation of lung spheroid cell-secreted factors
CA3170255A1 (en) * 2020-03-05 2021-09-10 Silviu Itescu Method for treating inflammatory lung diseases using mesenchymal lineage precursor or stem cells
US20230105667A1 (en) * 2020-03-12 2023-04-06 Exostem Biotec Ltd. Mesenchymal stromal cells and extracellular vesicles for treating viral infections, inflammation, and tissue fibrosis
BR112022020042A2 (pt) * 2020-04-03 2022-11-22 Mesoblast Int Sarl Método para tratar hiperinflamação com o uso de células-tronco ou precursoras de linhagem mesenquimal
EP4132479A1 (en) * 2020-04-07 2023-02-15 Ramot at Tel-Aviv University Ltd. Cannabidiol-containing compositions and uses thereof

Similar Documents

Publication Publication Date Title
JP2023534524A5 (https=)
Sohag et al. Revisiting potential druggable targets against SARS‐CoV‐2 and repurposing therapeutics under preclinical study and clinical trials: A comprehensive review
KR101571571B1 (ko) 황화 폴리사카라이드를 포함하는 항바이러스 조성물
BRPI0411856A (pt) composições e métodos para o aumento da atividade de telomerase
BRPI0512796A (pt) composto, processo para preparar o mesmo, composição farmacêutica, uso de um composto, e, métodos para produzir um efeito inibitório de b-raf, e um efeito anticáncer em um animal de sangue quente, e para tratar uma doença
JP2023518340A5 (https=)
WO2022010938A3 (en) Catalysis deactivated angiotensin-converting enzyme 2 (ace2) variants and their uses
Alshaeri et al. A contemporary look at COVID-19 medications: available and potentially effective drugs
ES2867049T3 (es) Composiciones de vacuna que comprenden un virus de Zika mutante atenuado
JP2024504225A5 (https=)
CN112439058A (zh) 基于外泌体为载体的重组新型冠状病毒纳米疫苗方法
RU2012146542A (ru) Способ ингибирования репликации вич в клетках млекопитающих и у людей
AU2018261420A1 (en) Method for treating ischemic tissue
WO2001089509A3 (en) Method of treating hiv-1 disease
Shah et al. A Review on Modern Use of Intranasal Vaccination in the Treatment of SARS-COV-2.
Zhang et al. Gene-and cell-based therapies in cardiovascular diseases
JP2008534621A5 (https=)
BR112022001138A2 (pt) Métodos de tratamento de esclerose múltipla
US20230030607A1 (en) Novel oxygen pulse therapy method for treating COVID19 and viral, bacterial, fungal or parasitic respiratory and other diseases
JP2025505673A5 (https=)
VIDHATE et al. A Review of Saponine rich herbal drugs on COVID–19 wsr to their Muco-adhesive action
WO2022159763A1 (en) Sars-cov-2 therapeutics
WO2021181044A1 (fr) Composition comprenant du diltiazem pour traiter l'infection virale par les virus sars-cov-2
JP5189088B2 (ja) 抗ウイルス剤
Asefy et al. Novel and promising approaches in COVID-19 treatment